openPR Logo
Press release

Industry Trends: Drugs for Non-small Cell Lung Cancer Market By Key Vendors: Menarini, Sanofi, Amgen 2018-2025

12-12-2018 07:02 AM CET | Industry, Real Estate & Construction

Press release from: QYresearchreports

QyResearchReports

QyResearchReports

Qyresearchreports include new market research report Drugs for Non-small Cell Lung Cancer to its huge collection of research reports.

This report focuses on the global Drugs for Non-small Cell Lung Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drugs for Non-small Cell Lung Cancer development in United States, Europe and China.

In 2017, the global Drugs for Non-small Cell Lung Cancer market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

The key players covered in this study
Bristol-Myers Squibb
GlaxoSmithKline
Menarini
Sanofi
Ziopharm Oncology
Alchemia
Amgen
...

Save UP TO 15% On All Reports: https://www.qyresearchreports.com/year-end-offer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Drugs for Non-small Cell Lung Cancer status, future forecast, growth opportunity, key market and key players.
To present the Drugs for Non-small Cell Lung Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

For more info, get sample report for FREE here: https://www.qyresearchreports.com/sample/sample.php?rep_id=1945382&type=S

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Drugs for Non-small Cell Lung Cancer Market Size Growth Rate by Type (2013-2025)
1.4.2 Radiofrequency Ablation (RFA)
1.4.3 Radiation Therapy
1.4.4 Chemotherapy
1.4.5 Targeted Therapies
1.4.6 Immunotherapy
1.5 Market by Application
1.5.1 Global Drugs for Non-small Cell Lung Cancer Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other

2 Global Growth Trends
2.1 Drugs for Non-small Cell Lung Cancer Market Size
2.2 Drugs for Non-small Cell Lung Cancer Growth Trends by Regions
2.2.1 Drugs for Non-small Cell Lung Cancer Market Size by Regions (2013-2025)
2.2.2 Drugs for Non-small Cell Lung Cancer Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

Browse Complete Research Report at: https://www.qyresearchreports.com/report/global-drugs-for-non-small-cell-lung-cancer-market-size-status-and-forecast-2018-2025.htm

3 Market Share by Key Players
3.1 Drugs for Non-small Cell Lung Cancer Market Size by Manufacturers
3.1.1 Global Drugs for Non-small Cell Lung Cancer Revenue by Manufacturers (2013-2018)
3.1.2 Global Drugs for Non-small Cell Lung Cancer Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Drugs for Non-small Cell Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Drugs for Non-small Cell Lung Cancer Key Players Head office and Area Served
3.3 Key Players Drugs for Non-small Cell Lung Cancer Product/Solution/Service
3.4 Date of Enter into Drugs for Non-small Cell Lung Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Drugs for Non-small Cell Lung Cancer Market Size by Type (2013-2018)
4.2 Global Drugs for Non-small Cell Lung Cancer Market Size by Application (2013-2018)

5 United States
5.1 United States Drugs for Non-small Cell Lung Cancer Market Size (2013-2018)
5.2 Drugs for Non-small Cell Lung Cancer Key Players in United States
5.3 United States Drugs for Non-small Cell Lung Cancer Market Size by Type
5.4 United States Drugs for Non-small Cell Lung Cancer Market Size by Application
...

List of Tables and Figures

Table Drugs for Non-small Cell Lung Cancer Key Market Segments
Table Key Players Drugs for Non-small Cell Lung Cancer Covered
Table Global Drugs for Non-small Cell Lung Cancer Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Drugs for Non-small Cell Lung Cancer Market Size Market Share by Type 2013-2025
Figure Radiofrequency Ablation (RFA) Figures
Table Key Players of Radiofrequency Ablation (RFA)
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Therapies Figures
Table Key Players of Targeted Therapies
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Table Global Drugs for Non-small Cell Lung Cancer Market Size Growth by Application 2013-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
...

About Us: QYResearchReports delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Web: http://www.qyresearchreports.com
Email: sales@qyresearchreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Industry Trends: Drugs for Non-small Cell Lung Cancer Market By Key Vendors: Menarini, Sanofi, Amgen 2018-2025 here

News-ID: 1433846 • Views: 91

More Releases from QYresearchreports

Global Oilfield Communication Equipment Market Latest Achievements and Opportuni …
Qyresearchreports include new market research report Global Oilfield Communication Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Oilfield Communication Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to
Global Power Over Ethernet (POE) Lighting Market : Key Growth Factors and Foreca …
Qyresearchreports include new market research report Global Power Over Ethernet (POE) Lighting Market Insights, Forecast to 2025 to its huge collection of research reports. This report presents the worldwide Power Over Ethernet (POE) Lighting market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities
Global Automatic Palletizer and Depalletizer Market to be at Forefront by 2025 | …
Qyresearchreports include new market research report Global Automatic Palletizer and Depalletizer Market Insights, Forecast to 2025 to its huge collection of research reports. Automatic palletizer and depalletizer is a machine that enables automatic stacking of goods and products. It also enables the depalletizing or unloading of goods. The rising consumer income and European Central Bank (ECB) bond-buying program will influence the buying pattern of consumers in EMEA and will result in
Global Weather Forecasting Equipment Market Advancement Analysis and Precise Out …
Qyresearchreports include new market research report Global Weather Forecasting Equipment Market Insights, Forecast to 2025 to its huge collection of research reports. The Weather Forecasting Equipment market was valued at Million US$ in 2018 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to

All 5 Releases


More Releases for Drugs

Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Immunotherapy Drugs Market
Immunotherapy drugs are used to treat cancer, infection, respiratory and autoimmune disorders. Immunotherapies either stimulate the activities done by specific components of the immune system or counteract the signals that are produced by the cancer cells and suppress the immune responses. The Immunotherapy Drugs Market accounted to USD 107 billion in 2016 growing at a CAGR of 13.2% during the forecast period of 2017 to 2024. The upcoming market report contains
Immunotherapy Drugs Market
Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some immunotherapies that suppress or reduce the immune response are known as suppression immunotherapies. Cell-based immunotherapies are useful for some types of cancers. Immune effector cells includingmacrophages, dendritic cells, lymphocytes, cytotoxic T lymphocytes (CTL), natural killer cells
Tardive Dyskinesia Drugs Market
Tardive dyskinesia (TD) is a form of dyskinesia that is difficult to treat. It is a nerve disorder characterized by involuntary movements such as jaw, lips, and tongue, considered as grimacing, sticking the tongue out, and lip smacking. Some other symptoms are an individual experiencing involuntary movement of the lower and upper extremities and also breathing choking. According to Center for Drug Evaluation and Research, tardive dyskinesia can lead to
Erythropoietin Drugs Market
Erythropoietin alfa is widely used to treat anemia and increase the red blood cells count in the body. Erythropoietin drugs are developed in vitro by extracting the erythropoietin from the human body and developing it through the use of recombinant DNA technology. Erythropoietin drugs are also used to treat anemia induced from cancer, multiple myloma and HIV associated anemia. Recombinant DNA technology has allowed researchers to develop synthetic forms of